2021
DOI: 10.1016/j.pharmthera.2021.107826
|View full text |Cite
|
Sign up to set email alerts
|

Cyclic nucleotide phosphodiesterase inhibitors as therapeutic interventions for cystic fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 202 publications
0
11
0
Order By: Relevance
“…In addition, embryonic stem cells-derived AT2 cells also express Cftr [ 58 ]. Persistent loss of this cluster, and thus Cftr expression with hyperoxia would bode poorly for maintenance of normal lung fluid balance and bacterial clearance even in adulthood, which could contribute to sustained tissue damage [ 59 , 60 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, embryonic stem cells-derived AT2 cells also express Cftr [ 58 ]. Persistent loss of this cluster, and thus Cftr expression with hyperoxia would bode poorly for maintenance of normal lung fluid balance and bacterial clearance even in adulthood, which could contribute to sustained tissue damage [ 59 , 60 ].…”
Section: Discussionmentioning
confidence: 99%
“…Another effect of targeting PDE4 is the cAMP/PKA-dependent gating of the CFTR channel, increasing airway surface liquid and facilitating mucus clearance ( 27 ). CFTR functional defects and mucus stasis can be observed in patients with COPD and certain forms of asthma ( 28 ) but are critical in CF ( 2 ).…”
Section: Discussionmentioning
confidence: 99%
“…PDE1C inhibition with IBMX (that inhibits all PDEs except PDE8) and PF-04957325 (PDE8 inhibitor) further increased I sc compared to inhibition using IBMX alone, suggesting that CFTR activity is modulated by different PDEs in different cell-types. In fact, other PDE family members, such as PDE3, 4 (see above) and 5, have already been implicated in CFTR regulation and the use of PDE inhibitors has already been proposed as a potential therapy for CF ( Turner et al, 2021 ).…”
Section: Cell Type-specific Regulation Of Cftrmentioning
confidence: 99%